Radiation therapy for locally advanced non-small cell lung cancer at Showa University Fujigaoka Hospital
-
- Imai Atsushi
- Radiation Oncology, Showa University Fujigaoka Hospital
-
- Ozawa Yukiko
- Radiation Oncology, Showa University Fujigaoka Hospital
-
- Shinjo Hidenori
- Radiation Oncology, Showa University Northern Yokohama Hospital
-
- Kobayashi Rei
- Department of Radiology, Division of Radiation Oncology, Showa University School of Medicine
-
- Murakami Kouzou
- Department of Radiology, Division of Radiation Oncology, Showa University School of Medicine
-
- Kato Masako
- Department of Radiology, Division of Radiation Oncology, Showa University School of Medicine
-
- Niiya Akifumi
- Department of Radiology, Division of Radiation Oncology, Showa University School of Medicine
-
- Toyofuku Kousuke
- Department of Radiology, Division of Radiation Oncology, Showa University School of Medicine
-
- Nishimura Emi
- Department of Radiology, Division of Radiation Oncology, Showa University School of Medicine
-
- Harada Ken
- Radiation Oncology, Showa University Northern Yokohama Hospital
-
- Morota Madoka
- Radiation Oncology, Showa University Koto Toyosu Hospital
-
- Sekimoto Atsuhito
- Radiation Oncology, Showa University Koto Toyosu Hospital
-
- Miyaura Kazunori
- Department of Radiology, Division of Radiation Oncology, Showa University School of Medicine
-
- Kagami Yoshikazu
- Department of Radiology, Division of Radiation Oncology, Showa University School of Medicine
-
- Ito Yoshinori
- Department of Radiology, Division of Radiation Oncology, Showa University School of Medicine
Bibliographic Information
- Other Title
-
- 昭和大学藤が丘病院における局所進行非小細胞肺癌の放射線治療成績と照射野設定に関する考察
Abstract
Radiation therapy plays an important role in the treatment of locally advanced non-small cell lung cancer （LA-NSCLC）. However, determining the optimal radiotherapy irradiation field for LA-NSCLC can be challenging. Herein, we analyzed the accumulated experience of radiotherapy for LA-NSCLC at Showa University Fujigaoka Hospital, to identify important considerations while creating radiotherapy treatment plans for LA-NSCLC. A total of 50 patients with LA-NSCLC who were treated with radiotherapy in our hospital were included in the study. The median overall survival and median progression-free survival times were 38.5 and 14.2 months, respectively. The two-year overall survival and two-year progression-free survival rates were 64.2％ and 32.1％, respectively. The treatment outcomes were similar to those reported by other researchers. Additionally, elective nodal failure occurred in two cases （4％）, both of which were upper lobe origin and treated with involved field radiation therapy. Elective nodal irradiation might be considered in cases of upper lobe origin unless the irradiated volume of the lung is elevated.
Journal
-
- Journal of The Showa University Society
-
Journal of The Showa University Society 83 (5), 325-333, 2023
The Showa University Society
- Tweet
Keywords
Details 詳細情報について
-
- CRID
- 1390298355901115648
-
- ISSN
- 2188529X
- 2187719X
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
-
- Abstract License Flag
- Disallowed